Concepedia
Statistics
Publications
9
Citations
597
H-Index
Active since
1987
Affiliations
UCB Pharma (Belgium)(Current)
UCB Pharma (France)
E. Baltes is an author at UCB Pharma (Belgium) specializing in pharmacology, medicine, and levetiracetam treatment.
Publications per year
1987–2005
A randomized, double‐blind, crossover comparison among cetirizine, levocetirizine, and ucb 28557 on histamine‐induced cutaneous responses in healthy adult volunteers
J.L. Devalia, F. Hanotte, E. Baltes et al. · Allergy · 2001 · 150 citations
Life Sciences, Pharmacology, Pharmacotherapy +15
Pharmacokinetics and metabolism of 14 C-levetiracetam, a new antiepileptic agent, in healthy volunteers
M. Strolin Benedetti, Rhys Whomsley, Jean‐Marie Nicolas et al. · European Journal of Clinical Pharmacology · 2003 · 105 citations
Medicine, Pharmacokinetics, Pharmacology +11
Repeated administration of the novel antiepileptic agent levetiracetam does not alter digoxin pharmacokinetics and pharmacodynamics in healthy volunteers
René H. Levy, Isabelle Ragueneau‐Majlessi, E. Baltes · Epilepsy Research · 2001 · 63 citations
Histamine H1 receptor occupancy and pharmacodynamics of second generation H1-antihistamines
Michel Gillard, M. Strolin Benedetti, Pierre Chatelain et al. · Inflammation Research · 2005 · 63 citations
Medicine, Pharmacology, Pharmacotherapy +9
Comparative pharmacokinetics and metabolism of levetiracetam, a new anti-epileptic agent, in mouse, rat, rabbit and dog
M. Strolin Benedetti, René Coupez, Rhys Whomsley et al. · Xenobiotica · 2004 · 63 citations
Medicine, Pharmacokinetics, Pharmacology +13
1–5 of 9